반응형
| Global Data Intelligence Center | ||
| 구분 | 보고서 (영문) | 업로드 날짜 |
| 제약/바이오/임상시험 | Positive Results from Rybrevant Trial Solidify Janssen’s Foothold in EGFR-Mutated NSCLC | 09-08-2023 |
| CureVac Highlights Shift in Seasonal Influenza Vaccines Development Pipeline | 09-14-2023 | |
| Novo Nordisk’s Wegovy to Start Being Supplied by NHS in England | 09-15-2023 | |
| Market Cap Rebound by Top 20 Biopharmaceutical Companies in Q2 2023 | 09-15-2023 | |
| Forxiga Flunks Primary Endpoint in DICTATE-AHF Trial | 09-21-2023 | |
| Alvotech’s AVT05 in Phase III Rheumatoid Arthritis Study, as the Sole Candidate | 09-21-2023 | |
| GSK’s Ojjaara Receives FDA Approval for Treating Myelofibrosis Patients with Anemia | 09-21-2023 | |
| Clinical Trials Feasibility, Risk Assessment and Planning for Success – A Case Study | 09-22-2023 | |
| 질환별 | Influence of Social Class on AIDS Incidence and Mortality in Brazil | 09-12-2023 |
| Heart Failure: Epidemiology Forecast to 2032 | 09-19-2023 | |
| Sepsis: 68-Market Analysis and Sales Forecast | 09-21-2023 | |
| Can Steatosis-Associated Fibrosis Estimator Scores Improve Diagnosis of Nonalcoholic Fatty Liver Disease? | 09-21-2023 | |
| New Evidence Shows Depression as a Major Risk for Type 2 Diabetes | 09-22-2023 | |
| High Global Prevalence of HPV in Sexually Active Men | 09-22-2023 | |
| The Burden of Hepatitis B and Hepatitis C-Related Illnesses | 09-22-2023 | |
| 컨퍼런스/심포지엄/학회 | Disparity in the Distance Between Disease Prevalent Populations and Trial Locations | 09-14-2023 |
| Could Gilead's Trodelvy Be the Next TROP-2 Therapy Game-Changer in NSCLC Treatment | 09-22-2023 | |
반응형
'의료기기관련기관 > 국가임상시험지원재단' 카테고리의 다른 글
| [국가임상시험지원재단] 해외 임상시험 정보데이터 (Global Data) 발간 보고서 제공 (0) | 2023.10.06 |
|---|---|
| [KoNECT] 해외 임상시험 정보 데이터(Global Data) 보고서 업데이트 안내 09.15(금) (0) | 2023.10.06 |
| [KoNECT] 해외 임상시험 정보 데이터(Global Data) 보고서 업데이트 안내 09.04(월) (0) | 2023.09.05 |
| [KoNECT] 해외 임상시험 정보 데이터(Global Data) 보고서 업데이트 안내 08.18(금) (0) | 2023.08.18 |
| [KoNECT] 해외 임상시험 정보 데이터(Global Data) 보고서 업데이트 안내 08.04(금) (0) | 2023.08.18 |